Milton S. Hershey Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Milton S. Hershey Medical Center sits in the top decile of US sponsors by registered trial count (#93 of 15,742 sponsors by registered trial count).

396 total trials 55 currently recruiting 255 completed early-phase tilt top decile by trial count

Milton S. Hershey Medical Center: 396 sponsored US clinical trials, 55 recruiting.

Milton S. Hershey Medical Center sponsors 396 registered US clinical trials on ClinicalTrials.gov, 55 of them currently recruiting, and 255 completed. 46 of these trials are in Phase 3-4 (later-stage) and 73 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Child Abuse, with 4 trials.

Top-decile sponsor footprint

Milton S. Hershey Medical Center ranks in the top decile of sponsors by registered trial count (#93 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 39/100

255 of 320 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

396 total, page 7 of 8

COMPLETED NA

Stress Reduction for Overweight or Obese Women Either With Polycystic Ovary Syndrome (PCOS) or Without PCOS (Non-PCOS)

NCT01464398

COMPLETED

Metabolizing Enzyme Genotype Versus Exemestane Metabolism Profiles

NCT01626144

COMPLETED NA

Effects of Involvement in a Group-based Creative Expression Program on Psychotropic Drug Use in Persons With Dementia

NCT01382693

COMPLETED NA

Exercise in Treatment Resistant Depression (TRD): A Feasibility Study

NCT01383811

COMPLETED

Reaching Exercise Goals: Comparison of Exercise Means in Patients With Knee Osteoarthritis

NCT01359124

TERMINATED NA

Metformin for the Treatment of Premature Pubarche in Girls

NCT01316042

COMPLETED NA

Study of Trazodone & Cognitive Behavioral Therapy to Treat Insomnia

NCT01348542

COMPLETED Phase 3

Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma

NCT01248065

COMPLETED NA

Probiotics in Primary Care

NCT01254097

COMPLETED Phase 3

Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.

NCT01272635

COMPLETED Early Phase 1

Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease

NCT01308242

COMPLETED Phase 4

Comparing Hemodynamic Changes for Intubation With Shikani Intubating Stylet and Macintosh Laryngoscope

NCT01271543

TERMINATED

Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells

NCT01286883

COMPLETED NA

Oropharyngeal Colostrum for Immune Stimulation in Very Low Birth Weight Infants

NCT01443091

COMPLETED NA

Exercise in Pregnancy for Reduction of Blood Pressure in Obese Patients

NCT01261884

COMPLETED NA

Comparing OTC Acne Treatment to Prescription Regimen

NCT01237821

COMPLETED NA

WalkLink: Internet-based Walking Program

NCT01142804

COMPLETED NA

Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome

NCT01107964

COMPLETED NA

Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?

NCT01159860

COMPLETED Phase 2

CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients

NCT00999713

COMPLETED Phase 2

High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma

NCT01124734

COMPLETED Phase 2

Behavioral Study to Control Blood Pressure

NCT01035554

COMPLETED NA

A Trial of Intravenous Fluids During Labor

NCT01110005

COMPLETED NA

Effect of Bright Light Treatment On Elders In a Long Term Care Environment

NCT01042587

COMPLETED NA

Oral Glutathione Supplementation on the Levels of Blood Glutathione

NCT01044277

COMPLETED

Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity

NCT00886535

COMPLETED NA

Adolescent Social Skills Training Program

NCT01031823

COMPLETED Phase 2

Improving the Quality of Asthma Care Using the Internet

NCT00921401

COMPLETED Phase 4

The Effects of Sildenafil on Exercise Function and Capacity in Patients With Fontan Circulation

NCT00964782

COMPLETED NA

The Use of Pedometers as an Adjunctive Tool in a School-based Pediatric Weight Management Program

NCT00921323

COMPLETED

The Effects of Written Emotional Disclosure on Eating Disorder Pathology in a Clinical Eating Disordered Population

NCT00766558

COMPLETED Phase 1

Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)

NCT00907153

TERMINATED Phase 2

Trial of RAD001 in Triple Negative Metastatic Breast Cancer

NCT00827567

COMPLETED Phase 1

JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia

NCT00860522

COMPLETED NA

Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

NCT00723398

TERMINATED Phase 1

Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias

NCT00882076

TERMINATED Phase 2

Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies

NCT00837200

COMPLETED Phase 4

Spinal Anesthesia Induced Hypotension During Cesarean Section

NCT00846651

COMPLETED Phase 4

Comparison of ProSeal Laryngeal Mask Airway to Laryngeal Mask Airway Supreme

NCT00836095

COMPLETED Phase 4

Comparing Fluticasone-salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep

NCT00731770

TERMINATED Phase 1

Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

NCT00783172

TERMINATED Phase 1

Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer

NCT00714246

COMPLETED Phase 2

Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women

NCT00704912

TERMINATED Phase 1

Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer

NCT00702962

COMPLETED Phase 3

CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)

NCT00675584

COMPLETED

Electromyography Evaluation of Subscapularis Function After Total Shoulder Arthroplasty

NCT00779974

COMPLETED NA

A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers

NCT00741026

TERMINATED NA

Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety

NCT00746239

COMPLETED

Long Term Prognosis of MRI Diagnosed Partial Thickness Tears of the Rotator Cuff

NCT00779415

COMPLETED Phase 2

The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease

NCT00715117

← Previous Page 7 of 8 Next →

Phase Distribution

PhaseTrial count
Phase 1 40
Phase 2 33
Phase 3 25
Phase 4 21

What is open in the Milton S. Hershey Medical Center pipeline

55 recruiting of 396 indexed (14% open); 255 completed (64%).

Phase mix: 46 late (III/IV) vs 73 early (I/II) (early-phase heavy).

Top condition: Child Abuse (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Milton S. Hershey Medical Center: open-pipeline peers nationwide

Peers matched on 396 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 10%12%14%16%18%20% Total trials Recruiting share Milton S. Hershey Medical CenterAbramson Cancer Center at Penn MedicineCase Comprehensive Cancer CenterUniversity of NebraskaTakedaUniversity of CincinnatiJohns Hopkins Bloomberg School of Public HealthBeiGeneSeattle Institute for Biomedical and Clinical Research
Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 396 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Milton S. Hershey Medical Center page

396 registered trials is a research-attention snapshot, not an endorsement of Milton S. Hershey Medical Center or any single study.

  • 55 of Milton S. Hershey Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Child Abuse is the condition Milton S. Hershey Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Child Abuse trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Milton S. Hershey Medical Center pipeline card: 396 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.